Literature DB >> 20935063

Smoking and selected DNA repair gene polymorphisms in controls: systematic review and meta-analysis.

M Elizabeth Hodgson1, Charles Poole, Andrew F Olshan, Kari E North, Donglin Zeng, Robert C Millikan.   

Abstract

BACKGROUND: When the case-only study design is used to estimate statistical interaction between genetic (G) and environmental (E) exposures, G and E must be independent in the underlying population, or the case-only estimate of interaction (COR) will be biased. Few studies have examined the occurrence of G-E association in published control group data.
METHODS: To examine the assumption of G-E independence in empirical data, we conducted a systematic review and meta-analysis of G-E associations in controls for frequently investigated DNA repair genes (XRCC1 Arg399Gln, Arg194Trp, or Arg280His, XPD Lys751Gln, and Asp312Asn, and XRCC3 Thr241Met), and smoking (ever/never smoking, current/not current smoker, smoking duration, smoking intensity, and pack-years).
RESULTS: Across the 55 included studies, single nucleotide polymorphisms SNP-smoking associations in controls (OR(z)) were not reliably at the null value of 1.0 for any SNP-smoking combinations. Two G-E combinations were too heterogeneous for summary estimates: XRCC1 399 and ever-never smoking (N = 21), and XPD 751 and pack-years (N = 12). OR(z) ranges for these combinations were: [OR(z) (95% confidence interval (CI)] 0.7 (0.4, 1.2)-1.9 (1.2, 2.8) and 0.8 (0.5, 1.3)-2.3 (0.8, 6.1), respectively). Estimates for studies considered homogeneous (Cochran's Q P-value <0.10) varied 2- to 5-fold. No study characteristics were identified that could explain heterogeneity.
CONCLUSIONS: We recommend the independence assumption be evaluated in the population underlying any potential case-only study, rather than in a proxy control group(s) or pooled controls. IMPACT: These results suggest that G-E association in controls may be population-specific. Increased access to control data would improve evaluation of the independence assumption. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935063      PMCID: PMC3108462          DOI: 10.1158/1055-9965.EPI-10-0877

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  89 in total

1.  A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk.

Authors:  Jiali Han; Susan E Hankinson; Immaculata De Vivo; Donna Spiegelman; Rulla M Tamimi; Harvey W Mohrenweiser; Graham A Colditz; David J Hunter
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

2.  Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA.

Authors:  Pavel Vodicka; Rajiv Kumar; Rudolf Stetina; Somali Sanyal; Pavel Soucek; Vincent Haufroid; Maria Dusinska; Miroslava Kuricova; Maria Zamecnikova; Ludovit Musak; Jana Buchancova; Hannu Norppa; Ari Hirvonen; Ludmila Vodickova; Alessio Naccarati; Zora Matousu; Kari Hemminki
Journal:  Carcinogenesis       Date:  2004-01-16       Impact factor: 4.944

3.  Genetic dissection methods: designs used for tests of gene-environment interaction.

Authors:  Xin Liu; M Daniele Fallin; W H Linda Kao
Journal:  Curr Opin Genet Dev       Date:  2004-06       Impact factor: 5.578

4.  Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction.

Authors:  Elisabete Ramos; Carla Lopes; Henrique Barros
Journal:  Ann Epidemiol       Date:  2004-07       Impact factor: 3.797

5.  Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.

Authors:  Min Shen; Rayjean J Hung; Paul Brennan; Christian Malaveille; Francesco Donato; Donatella Placidi; Angela Carta; Agnes Hautefeuille; Paolo Boffetta; Stefano Porru
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-11       Impact factor: 4.254

6.  Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK.

Authors:  Alessandra A Affatato; Kevin J Wolfe; Mirtha S Lopez; Csilla Hallberg; Marinel M Ammenheuser; Sherif Z Abdel-Rahman
Journal:  Environ Mol Mutagen       Date:  2004       Impact factor: 3.216

7.  Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer.

Authors:  Carsten Harms; Salama A Salama; Carlos H Sierra-Torres; Nohelia Cajas-Salazar; William W Au
Journal:  Environ Mol Mutagen       Date:  2004       Impact factor: 3.216

8.  Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis.

Authors:  Ichiro Inoshima; Kazuyoshi Kuwano; Naoki Hamada; Michihiro Yoshimi; Takashige Maeyama; Naoki Hagimoto; Yoichi Nakanishi; Nobuyuki Hara
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-04       Impact factor: 5.464

9.  DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk.

Authors:  Hong-Ping Yu; Xiao-Yong Zhang; Xiao-Li Wang; Lu-Yuan Shi; Yuan-Yuan Li; Fang Li; Yan-Hua Su; You-Jie Wang; Bin Lu; Xi Sun; Wen-Hong Lu; Shun-Qing Xu
Journal:  Cancer Detect Prev       Date:  2004

10.  Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.

Authors:  Jane C Figueiredo; Julia A Knight; Laurent Briollais; Irene L Andrulis; Hilmi Ozcelik
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-04       Impact factor: 4.254

View more
  6 in total

1.  The case-only independence assumption: associations between genetic polymorphisms and smoking among controls in two population-based studies.

Authors:  M Elizabeth Hodgson; Andrew F Olshan; Kari E North; Charles L Poole; Donglin Zeng; Chiu-Kit Tse; Tope O Keku; Joseph Galanko; Robert Sandler; Robert C Millikan
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

2.  Gene-environment interactions between ERCC2, ERCC3, XRCC1 and cadmium exposure in nasal polyposis disease.

Authors:  Rim Khlifi; Pablo Olmedo; Fernando Gil; Boutheina Hammami; Amel Hamza-Chaffai; Ahmed Rebai
Journal:  J Appl Genet       Date:  2016-11-12       Impact factor: 3.240

3.  Sequence Variants and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium.

Authors:  Shu-Chun Chuang; Antonio Agudo; Wolfgang Ahrens; Devasena Anantharaman; Simone Benhamou; Stefania Boccia; Chu Chen; David I Conway; Eleonora Fabianova; Richard B Hayes; Claire M Healy; Ivana Holcatova; Kristina Kjaerheim; Pagona Lagiou; Philip Lazarus; Tatiana V Macfarlane; Manoj B Mahimkar; Dana Mates; Keitaro Matsuo; Franco Merletti; Andres Metspalu; Hal Morgenstern; Joshua Muscat; Gabriella Cadoni; Andrew F Olshan; Mark Purdue; Heribert Ramroth; Peter Rudnai; Stephen M Schwartz; Lorenzo Simonato; Elaine M Smith; Erich M Sturgis; Neonilia Szeszenia-Dabrowska; Renato Talamini; Peter Thomson; Qingyi Wei; David Zaridze; Zuo-Feng Zhang; Ariana Znaor; Paul Brennan; Paolo Boffetta; Mia Hashibe
Journal:  Front Oncol       Date:  2011-07-12       Impact factor: 6.244

4.  XRCC1 Arg399Gln was associated with repair capacity for DNA damage induced by occupational chromium exposure.

Authors:  Xuhui Zhang; Xuan Zhang; Lei Zhang; Qing Chen; Zhangping Yang; Jingmin Yu; Hong Fu; Yimin Zhu
Journal:  BMC Res Notes       Date:  2012-05-29

5.  Are SNP-Smoking Association Studies Needed in Controls? DNA Repair Gene Polymorphisms and Smoking Intensity.

Authors:  Zoraida Verde; Luis Reinoso; Luis Miguel Chicharro; Pilar Resano; Ignacio Sánchez-Hernández; Jose Miguel Rodríguez González-Moro; Fernando Bandrés; Félix Gómez-Gallego; Catalina Santiago
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

6.  DNA Repair Gene (XRCC1) Polymorphism (Arg399Gln) Associated with Schizophrenia in South Indian Population: A Genotypic and Molecular Dynamics Study.

Authors:  S P Sujitha; D Thirumal Kumar; C George Priya Doss; K Aavula; R Ramesh; S Lakshmanan; S Gunasekaran; G Anilkumar
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.